NYSEAMERICAN:BVX - Bovie Medical Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $6.48 0.00 (0.00 %) (As of 03/19/2019 04:39 AM ET)Previous Close$6.48Today's Range$6.48 - $6.4852-Week Range$2.28 - $7.70VolumeN/AAverage Volume136,878 shsMarket Capitalization$215.14 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Bovie Medical Corporation, a medical device company, develops, manufactures, and markets electrosurgical devices and technologies, and related medical products used in doctor's offices, surgery centers, and hospitals worldwide. The company provides electrosurgical products, including desiccators, generators, electrodes, electrosurgical pencils, and various ancillary disposable products used during surgical procedures in gynecology, urology, plastic surgery, dermatology, veterinary, and other surgical markets for the cutting and coagulation of tissue. It also offers electrosurgical disposables comprising Resistick II, a proprietary coating applied to stainless steel that resist eschar during surgery; and disposable laparoscopic electrodes for use by physicians in the areas of gynecology, general surgery, and urology. In addition, the company provides battery operated cauteries for precise hemostasis in ophthalmology; nerve locator stimulator primarily used for identifying motor nerves in hand and facial reconstructive surgery; penlights for use in offices; and specialty lighting instruments for use in ophthalmology, as well as distributes specialty lighting instruments for general surgery, hip replacement surgery, and endotracheal tubes placement. Further, it develops J-Plasma, a patented helium-based plasma surgical product, as well as designs, develops, and manufactures electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing agreements. Bovie Medical Corporation markets its products to distributors under own brands, such as Bovie, IDS, and DERM, as well as under a private label. The company was formerly known as An-Con Genetics Inc. and changed its name to Bovie Medical Corporation in October 1998. Bovie Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida. Receive BVX News and Ratings via Email Sign-up to receive the latest news and ratings for BVX and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSEAMERICAN Industry Medical Instruments & Supplies Sub-IndustryN/A SectorMedical Current SymbolNYSEAMERICAN:BVX Previous SymbolAMEX:BVX CUSIPN/A CIK719135 Webwww.boviemedical.com Phone+1-727-3842323Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares33,200,000Market Cap$215.14 million Next Earnings DateN/A OptionableOptionable Bovie Medical (NYSEAMERICAN:BVX) Frequently Asked Questions What is Bovie Medical's stock symbol? Bovie Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "BVX." How were Bovie Medical's earnings last quarter? Bovie Medical Co. (NYSEAMERICAN:BVX) posted its quarterly earnings results on Thursday, November, 1st. The medical device company reported ($0.01) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.09) by $0.08. The medical device company had revenue of $3.67 million for the quarter, compared to analyst estimates of $3.67 million. The business's revenue was up 38.5% on a year-over-year basis. During the same period in the prior year, the company posted ($0.09) earnings per share. View Bovie Medical's Earnings History. What price target have analysts set for BVX? 2 analysts have issued twelve-month target prices for Bovie Medical's stock. Their predictions range from $8.50 to $11.00. On average, they expect Bovie Medical's share price to reach $9.75 in the next twelve months. This suggests a possible upside of 50.5% from the stock's current price. View Analyst Price Targets for Bovie Medical. What is the consensus analysts' recommendation for Bovie Medical? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bovie Medical in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Bovie Medical. Has Bovie Medical been receiving favorable news coverage? Headlines about BVX stock have been trending somewhat positive this week, according to InfoTrie. The research group rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Bovie Medical earned a news impact score of 0.7 on InfoTrie's scale. They also gave news coverage about the medical device company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the immediate future. Who are some of Bovie Medical's key competitors? Some companies that are related to Bovie Medical include Advanced Medical Solutions Group (AMS), TransEnterix (TRXC), Clover (CLV), CRH Medical (CRH), Apyx Medical (APYX), CRH Medical (CRHM), Tristel (TSTL), SDI (SDI), InfuSystem (INFU), Daxor (DXR), TSO3 (TOS), Retractable Technologies (RVP), IsoRay (ISR), IsoRay (ISR) and Omega Diagnostics Group (ODX). What other stocks do shareholders of Bovie Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Bovie Medical investors own include Geron (GERN), Endocyte (ECYT), Ampliphi Biosciences (APHB), TransEnterix (TRXC), SLS International (SLS), Aware (AWRE), Advaxis (ADXS), ENGlobal (ENG), Micron Technology (MU) and Palatin Technologies (PTN). Who are Bovie Medical's key executives? Bovie Medical's management team includes the folowing people: Mr. Charles D. Goodwin II, Pres, CEO & Director (Age 52)Mr. Jay D. Ewers, CFO, Treasurer & Sec. (Age 57)Mr. Moshe Citronowicz, Sr. VP (Age 65)Mr. Todd Hornsby, VP & GM of Advanced EnergyMr. Jeffrey Rencher, VP of Sales & Marketing - Surgical Products (Age 51) Who are Bovie Medical's major shareholders? Bovie Medical's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include RTW Investments LP (7.20%), Royce & Associates LP (2.09%), Cowen Prime Services LLC (1.00%), Essex Investment Management Co. LLC (0.80%), Raymond James Financial Services Advisors Inc. (0.67%) and Dimensional Fund Advisors LP (0.41%). View Institutional Ownership Trends for Bovie Medical. Which major investors are selling Bovie Medical stock? BVX stock was sold by a variety of institutional investors in the last quarter, including White Pine Capital LLC, Northern Trust Corp, Essex Investment Management Co. LLC, Royce & Associates LP, Raymond James Financial Services Advisors Inc., Creative Financial Designs Inc. ADV and Cambridge Investment Research Advisors Inc.. View Insider Buying and Selling for Bovie Medical. Which major investors are buying Bovie Medical stock? BVX stock was bought by a variety of institutional investors in the last quarter, including RTW Investments LP, Barclays PLC, Alambic Investment Management L.P., Acadian Asset Management LLC, Dimensional Fund Advisors LP, Dimensional Fund Advisors LP, Bailard Inc. and Cowen Prime Services LLC. View Insider Buying and Selling for Bovie Medical. How do I buy shares of Bovie Medical? Shares of BVX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Bovie Medical's stock price today? One share of BVX stock can currently be purchased for approximately $6.48. How big of a company is Bovie Medical? Bovie Medical has a market capitalization of $215.14 million. What is Bovie Medical's official website? The official website for Bovie Medical is http://www.boviemedical.com/. How can I contact Bovie Medical? Bovie Medical's mailing address is 4 Manhattanville Rd Ste 106, PURCHASE, NY 10577-2119, United States. The medical device company can be reached via phone at +1-727-3842323. MarketBeat Community Rating for Bovie Medical (NYSEAMERICAN BVX)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 118 (Vote Outperform)Underperform Votes: 140 (Vote Underperform)Total Votes: 258MarketBeat's community ratings are surveys of what our community members think about Bovie Medical and other stocks. Vote "Outperform" if you believe BVX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BVX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/19/2019 by MarketBeat.com StaffFeatured Article: What causes a recession?